The proposed study will focus on possible effects of statins on muscle strength and quality of life, and measurements to understand why muscles of statin users are not able to fully utilize fats. The investigators are specifically interested in statin users and the impact of muscle symptoms on daily activities and quality of life.~This study hypothesizes that patients with likely statin-associated myopathy have a metabolic dysregulation in fuel utilization such that compared to patients continuing statins, those on placebo will show:~improved INQoL and SF-36 scores (primary end point)~alleviation of muscle symptoms,~increased utilization of fatty acids as a fuel source reflected by the metabolic test results~decreased IMCL~improved insulin sensitivity.
The proposed study will focus on possible effects of statins on muscle strength and why they become tired more easily, quality of life, and measurements to understand why muscles are not able to fully utilize fats. The investigators are specifically interested in statin users and the impact of muscle symptoms on daily activities and quality of life.~This study hypothesize that patients with likely statin-associated myopathy have a metabolic dysregulation in fuel utilization such that compared to patients continuing statins, those on placebo will show:~improved Individualized Neuromuscular Quality of Life (INQoL) and Short Form-36 (SF-36) scores (primary end point)~alleviation of muscle symptoms,~increased utilization of fatty acids as a fuel source reflected by the metabolic test results~decreased intramyocellular lipid (IMCL)~improved insulin sensitivity.